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Hair Cortisol as a Biomarker of Stress
in Mindfulness Training for Smokers
Simon B. Goldberg, BA,1,2 Alison R. Manley, BA,3 Stevens S. Smith, PhD,3,4 Jeffrey M. Greeson, PhD,5,6
Evan Russell, MS,7 Stan Van Uum, MD, PhD,8 Gideon Koren, MD,9,10 and James M. Davis, MD 3,4

Abstract

Objectives: Stress is a well-known predictor of smoking relapse, and cortisol is a primary biomarker of stress.
The current pilot study examined changes in levels of cortisol in hair within the context of two time-intensity
matched behavioral smoking cessation treatments: mindfulness training for smokers and a cognitive-behavioral
comparison group.
Participants: Eighteen participants were recruited from a larger randomized controlled trial of smoking cessation.
Outcome Measures: Hair samples (3 cm) were obtained 1 month after quit attempt, allowing for a retrospective
analysis of hair cortisol at preintervention and post–quit attempt time periods. Self-reported negative affect was
also assessed before and after treatment.
Intervention: Both groups received a 7-week intensive intervention using mindfulness or cognitive-behavioral
strategies.
Results: Cortisol significantly decreased from baseline to 1 month after quit attempt in the entire sample (d = - 0.35;
p = .005). In subsequent repeated-measures analysis of variance models, time by group and time by quit status
interaction effects were not significant. However, post hoc paired t tests yielded significant pre–post effects
among those randomly assigned to the mindfulness condition (d = - 0.48; p = .018) and in those abstinent at post-test
(d = - 0.41; p = .004). Decreased hair cortisol correlated with reduced negative affect (r = .60; p = .011).
Conclusions: These preliminary findings suggest that smoking cessation intervention is associated with decreased hair cortisol levels and that reduced hair cortisol may be specifically associated with mindfulness
training and smoking abstinence. Results support the use of hair cortisol as a novel objective biomarker in
future research.

Introduction

Q

uitting smoking is notoriously difficult, and high
relapse rates in smokers have encouraged investigation
of physiologic and psychological processes associated with
smoking and smoking cessation. Cortisol is a glucocorticoid
hormone that plays a key regulatory role in the immune,
metabolic, and central nervous systems.1 The hypothalamicpituitary-adrenocortical (HPA) axis, which regulates cortisol

secretion, is highly responsive to nicotine.2 Smokers display
higher salivary cortisol levels relative to nonsmokers,3–5 with
cortisol decreasing when smokers quit.4,6,7 Increased cortisol
in smokers is generally believed to be attributable to nicotine
exposure.4
While the effects of smoking on cortisol have been consistent and robust, findings on cortisol as a predictor of
smoking behavior have been less consistent and less intuitive. For example, lower levels of absolute salivary cortisol
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and decreases in mean salivary cortisol have been associated
with an increased risk for smoking relapse, increased selfreported ratings of smoking urges, and increased withdrawal
related distress.6–8 Therefore, researchers have investigated
additional variables that could further explain variability in
smoking cessation outcomes.
Negative affect is a potent risk factor for smoking relapse9 and may form a link between cortisol and smoking. A
substantial body of research supports an affective model of
nicotine dependence, with nicotine use maintained through
negative reinforcement with the expectation that substance
use will alleviate unpleasant feelings.9
Acute and chronic negative affect have been linked to
HPA axis activity.10,11 Chronic stress exposure has been
linked in meta-analysis12 to a flatter diurnal cortisol slope
(Cohen d = 0.39) and a higher daily cortisol output volume
(d = 0.31). Higher cortisol levels have also been associated
with higher ratings of subjective distress13 and rise and fall
in tandem with changes in negative affect.14
Taken together, these findings linking negative affect,
increased risk of smoking relapse, and increased cortisol
output under stress suggest that stress reduction interventions designed to cultivate emotion regulation skills and
target social-emotional processes could conceivably aid
smoking cessation, and may be marked by lower levels of
cortisol.
Historically, cortisol has been assessed through plasma,
saliva, or urine, all of which are reliable methods for obtaining real-time estimates of cortisol in the body.12 While
these methods provide valuable insight into short-term
fluctuations in cortisol secretion, their experimental or clinical use presents substantial challenges. Serum and saliva
cortisol are highly responsive to diurnal physiologic processes and respond quickly to environmental stressors, yet
these methods are susceptible to technical problems with
sample collection and processing, often leading to substantial missing data. Urinary cortisol provides information on
HPA axis activity over a somewhat longer period of time,
but sample collection is time intensive and provides only
limited information on mean cortisol output over weeks or
months.
Hair cortisol measurement is a novel assessment method
gaining popularity and validity in the past decade.15,16 To
date, hair cortisol correlates highly with other methods of
cortisol measurement in both humans and animals.17,18
Levels have also been shown to change in expected directions in response to well-characterized stressors such as
peer-raising in macaques19 and the third trimester of human
pregnancy.20 Hair cortisol is also responsive to substance
abuse, with higher hair cortisol levels found in alcoholdependent participants during an active drinking phase
compared with abstinent alcohol-dependent participants or
controls.21
Hair cortisol holds substantial promise for measuring
HPA axis activity because sample collection is simple (see
Materials and Methods below). In addition, it is possible to
assess changes over the course of several months in a single
sample,15 thereby reducing vulnerability to missing data.
Hair cortisol may be particularly useful for assessing phenomena involving long-term affective changes, such as
those that might occur in the context of alternative and complementary medicine interventions.
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The current pilot study sought to examine changes in hair
cortisol in a subsample of smokers participating in a larger
randomized trial of smoking cessation comparing mindfulness
training for smokers22 (MTS) to a cognitive-behavioral therapy
(CBT) active control group. Mindfulness-based interventions
have demonstrated efficacy for reducing stress in both clinical
and nonclinical populations.23 Support exists for applications
of mindfulness to a range of medical and psychological conditions, including substance use disorders.24,25 Evidence for the
impact of mindfulness-based interventions on cortisol, however, remains mixed.26 For example, Marcus et al.27 reported
significant decreases in the cortisol awakening response in a
sample of 21 individuals receiving Mindfulness-Based Stress
Reduction (MBSR) within residential substance abuse treatment, while others28 failed to detect pre–post differences for
MBSR participants in a self-selected community sample. Difficulties in salivary cortisol measurement (e.g., diurnal fluctuation) may present a key methodologic barrier to accurate
assessment.26 Hair cortisol assessment may provide an alternative method—one less susceptible to the aforementioned
methodologic challenges with cortisol measurement—for indexing HPA axis-relevant physiologic effects.
The current pilot study examined changes in hair cortisol
in a sample of smokers participating in a randomized trial
comparing MTS22,29 to a time-intensity matched CBT
control group. Mindfulness-based interventions have demonstrated efficacy for reducing stress23 and specifically for
the treatment of substance abuse.24,25 Evidence for the use
of cortisol as a useful biomarker in mindfulness-based interventions, however, remains inconclusive.26
The pilot study was designed to answer the following
questions:
Q1. Is participation in a smoking cessation intervention
associated with a decrease in hair cortisol levels?
Q2. Do intervention effects on hair cortisol differ by
treatment type (i.e., mindfulness vs. CBT)?
Q3. Is smoking abstinence following an intervention associated with decreased hair cortisol levels?
Q4. Are changes in hair cortisol associated with changes
in negative affect?
Materials and Methods
Study design

Participants were randomly assigned to receive one of two
time-intensity matched 7-week behavioral smoking cessation interventions: MTS22 or Freedom from Smoking Enhanced (FFS-E, based on Freedom from Smoking).30 The
MTS group received mindfulness instruction and the FFS-E
group received relaxation and CBT strategies targeted to
smoking cessation. Both groups had a total of eight meetings,
made quit attempts approximately 1 month after the first
meeting, and received 2 weeks’ worth of nicotine patches.
The institutional review board approved all study procedures
and participants provided informed consent.
Participants

The larger randomized trial included 175 adult smokers;
135 participants elected to be randomly assigned to a highintensity intervention (MTS or FFS-E), and 86 attended a
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1-month postquit study visit. To qualify for hair donation for
the cortisol substudy, individuals must have attended five or
more of the eight MTS or FFS-E classes and the 1-month
postquit study visit. On the basis of guidelines from prior
studies,17,31 participants were excluded from hair donation if
they reported using dye or bleach on their hair in the past
year, were younger than age 25 or older than age 65 years,
or were currently using pharmaceutical glucocorticoids.
The hair cortisol substudy sample included 18 individuals
drawn from an eligible pool of 36 who were offered $30 to
donate 3 cm of hair. When compared at baseline to the eligible participants who did not donate hair, the substudy sample
was more likely to be female ( p = .015), smoke fewer cigarettes per day ( p = .029), and report lower nicotine dependence on the Fagerström Test for Nicotine Dependence
( p = .025). No other differences were noted between the
substudy sample and the eligible sample.
Measures
Baseline demographic questionnaire. At baseline, all
participants completed a brief questionnaire that assessed
demographic characteristics and smoking history.
Smoking status. Biochemically confirmed 7-day point
prevalence abstinence was assessed. A cutoff of 7.0 parts
per million exhaled carbon monoxide32 was used to confirm
abstinence.
Nicotine dependence. The Fagerström Test for Nicotine
Dependence33 was administered at baseline to assess severity of smoking addiction (a = .60 in the current trial).
Negative affect. The Depression Anxiety Stress Scale34
asks participants to rate negative affect and somatic symptoms over the past week. The total score was used in analyses (a = .95 in the current trial), with higher scores
indicating greater negative affect.
Hair cortisol. A single 3-cm hair sample was obtained
from each participant at the 1-month postquit study visit. On
the basis of previous work,35 the 1-cm segment most
proximal to the scalp was assayed to indicate postquit cortisol output. The second most proximal 1-cm segment, representing the month before the quit day, was not analyzed.
The third most proximal 1-cm segment was assayed to indicate cortisol output the month before the intervention.
Hair samples were analyzed by following standard procedures.17 Cortisol concentrations were adjusted to mass to
provide a hair cortisol concentration in picograms of cortisol

per milligram of hair. Intra- and interassay coefficients of
variation were 6.1% and 10.6%, respectively.
Data analysis

Repeated-measures analysis of variance (RMANOVA;
SPSS software, version 18.0; SPSS, Inc., Chicago, Illinois),
independent and paired t-tests, and Pearson correlations
were used. Effect sizes were computed as Cohen36 d using
the post–pre mean difference divided by the pooled standard
deviation.
Results

Demographic characteristics of the study sample included
the following: white, 88.9%; female, 55.6%; education
beyond high school, 77.8%; and average age, 42.2 – 11.4
years. Smoking history variables were as follows: years
smoked, 22.3 – 9.7; cigarettes per day, 14.5 – 5.3; past quit
attempts, 6.0 – 6.7; average Fagerström Test for Nicotine
Dependence score, 3.6 – 1.6. The MTS and FFS-E groups
did not differ at baseline for any tested variable ( p > .10).
Biochemically confirmed 7-day point prevalence smoking
abstinence at 1 month after quitting did not differ by group:
MTS, 80.0%; FFS-E, 62.5% (Pearson’s chi-square [1] = .68;
p = .410).
A significant main effect for time was found in an RMANOVA model with hair cortisol as the outcome and no other
predictors (F[1,17] = 10.43; p = .005; post–pre d = - 0.35).
The main effect for time remained significant in a model that
included group and a time-by-group interaction as predictors
of change in hair cortisol (F[1,16] = 9.70; p = .007), although
the time-by-group interaction was not significant (F[1,16] =
1.40; p = .254). The main effect for time also remained significant in a model predicting cortisol with quit status and a
time-by-quit status interaction as predictors (F[1,16] = 6.05;
p = .026), although the time-by-quit status interaction was not
significant (F[1,16] = .92; p = .353).
Paired samples t-tests were used post hoc to examine
within-group change in hair cortisol (Table 1). Cortisol significantly decreased in the MTS group (t[9] = 2.89; p = .018;
d = - 0.48) but not the FFS-E group (t[7] = 1.56; p = .162;
d = - 0.22). A significant drop in cortisol was found in the
quit group (t[12] = 3.51; p = .004; d = - 0.41) but not the
relapsed group (t[4] = 0.74; p = .502; d = - 0.20).
One outlier (3 standard deviations below the mean) was
found for change in negative affect and was removed before

Table 1. Pre–Post Changes in Hair Cortisol Reported for Full Sample and Subsamples
Group
Full sample
Quit
Relapsed
MTS
FFS-E

Participants
(n)

Baseline cortisol
level (pg/mg)

Postquit cortisol
level (pg/mg)

t-statistic

p-Value

d-Value

18
13
5
10
8

220.07 – 87.75
207.26 – 92.10
253.38 – 73.20
197.68 – 89.83
248.06 – 81.93

190.56 – 80.88
172.30 – 77.14
238.02 – 77.82
158.60 – 73.38
230.51 – 75.38

3.23
3.51
0.74
2.89
1.56

.005*
.004*
.502
.018**
.162

- 0.35
- 0.41
- 0.20
- 0.48
- 0.22

Cortisol values are expressed as mean – standard deviation.
*p < .01; **p < .05.
d, Cohen d (1988) computed by using post–pre mean difference divided by pooled standard deviation; MTS, mindfulness training for
smokers; FFS-E, Freedom from Smoking Enhanced.
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The significant positive correlations in the expected direction between changes in hair cortisol and changes in selfreported negative affect support the notion that hair cortisol
may be a useful biomarker for psychological stress (Q4).
In conclusion, this pilot study found that participation in
an intensive behavioral treatment for smoking cessation is
associated with decreased hair cortisol. This is meaningful
given that hair sampling provides a measure of long-term
cortisol secretion, not easily ascertained through other means
(i.e., blood or saliva). The additional findings are intriguing
but require replication in a larger sample. Overall, this study
supports hair cortisol as a straightforward, objective biomarker for use in future studies, particularly interventions
designed to affect health through changes in stress.
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17. Sauvé B, Koren G, Walsh G, Tokmakejian S, Van Uum S.
Measurement of cortisol in human hair as a biomarker of
systemic exposure. Clin Invest Med 2007;30:E183–E191.
18. Manenschijn L, Koper JW, Lamberts SW, van Rossum EF.
Evaluation of a method to measure long term cortisol levels. Steroids 2011;76:1032–1036.
19. Feng X, Wang L, Yang S, et al. Maternal separation produces lasting changes in cortisol and behavior in rhesus
monkeys. Proc Natl Acad Sci U S A 2011;108:14312–
14317.
20. Kirschbaum C, Tietze A, Skoluda N, Dettenborn L. Hair as
a retrospective calendar of cortisol production—increased
cortisol incorporation into hair in the third trimester of
pregnancy. Psychoneuroendocrinology 2009;34:32–37.
21. Stalder T, Kirschbaum C, Heinze K, al. Use of hair cortisol
analysis to detect hypercortisolism during active drinking
phase in alcohol-dependent individuals. Biol Psychol 2010;
85;357–360.
22. Davis JM, Fleming M, Bonus K, Baker T. A pilot study on
mindfulness based stress reduction for smokers. BMC
Complement Altern Med 2007;7.
23. Khoury B, Lecomte T, Fortin G, et al. Mindfulness-based
therapy: a comprehensive meta-analysis. Clin Psychol Rev
2013;33:763–771.

GOLDBERG ET AL.

24. Zgierska A, Rabago D, Chawla N, Kushner K, Koehler R,
Marlatt A. Mindfulness meditation for substance use disorders: a systematic review. Subst Abuse 2009;30:266–294.
25. Khanna S, Greeson JM. A narrative review of yoga and
mindfulness as complimentary therapies for addiction.
Complement Ther Med 2013;21:244–252.
26. Matousek R, Dobkin P, Pruessner J. Cortisol as a marker
for improvement in mindfulness-based stress reduction.
Complement Ther Clin Pract 2010;16:13–19.
27. Marcus MT, Fine PM, Moeller FG, Khan MM, Pitts K,
Swank PR, Liehr P. Change in stress levels following
mindfulness-based stress reduction in a therapeutic community. Addict Disord Their Treat 2003;2:63–68.
28. Galantino M, Baime M, Maguire M, Szapary P, Farrar J.
Association of psychological and physiological measures
of stress in health-care professionals during an 8-week
mindfulness meditation program: mindfulness in practice.
Stress Health 2005;21:255–261.
29. Davis JM, Goldberg SB, Anderson MC, Manley AR, Smith
SS, Baker TB. Randomized trial on Mindfulness Training
for Smokers targeted to a disadvantaged population. Subst
Use Misuse 2014;49:571–585.
30. Lando H, McGovern P, Barrios F, Etringer B. Comparative
evaluation of American Cancer Society and American
Lung Association smoking cessation clinics. Am J Public
Health 1990;80:554–559.
31. Pereg D, Gow R, Mosseri M, et al. Hair cortisol and the risk
for acute myocardial infarction in adult men. Stress 2011;
14:73–81.
32. Middleton E, Morice A. Breath carbon monoxide as an
indication of smoking habit. Chest 2000;117:758–763.
33. Heatherton T, Kozlowski L, Frecker R, Fagerstrom K. The
Fagerström Test for Nicotine Dependence: a revision of the
Fagerström Tolerance Questionnaire. Br J Addict 1991;86:
1119–1127.
34. Lovibond SH, Lovibond PF. Manual for the Depression
Anxiety Stress Scales. 2nd ed. Sydney, Australia: Psychology Foundation, 1995.
35. Wennig R. Potential problems with the interpretation of
hair analysis results. Forensic Sci Int 2000;107:5–12.
36. Cohen J. Statistical Power Analysis for the Behavioral
Sciences. 2nd ed. Erlbaum, NJ: Routledge, 1997.

Address correspondence to:
Simon B. Goldberg
Department of Counseling Psychology
University of Wisconsin
335 Education Building
1000 Bascom Mall
Madison, WI 53706
E-mail: sbgoldberg@wisc.edu

